Other
Neoplasm by Obsolete Classification
CI-CAN-00000033Explore in graph →
Non-malignant11 active trials5 evidence items
- NCIt
- C45230
Loading cancer entity…
Other
CI-CAN-00000033Explore in graph →
Clinical trials
51 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03016091 | A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma | terminated | Phase 2 | 18 | Rabin Medical CenterOTHER | 1 | Feb 18, 2025 | clinicaltrials |
| NCT00119366 | Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome | terminated | Phase 2 | 18 | Fred Hutchinson Cancer CenterOTHER | 1 | Dec 12, 2022 |
| clinicaltrials |
Data updated 22 days agoSource updated Feb 18, 2025source: clinicaltrials